Logo image of ISRG

INTUITIVE SURGICAL INC (ISRG) Stock Fundamental Analysis

NASDAQ:ISRG - Nasdaq - US46120E6023 - Common Stock - Currency: USD

544.82  +4.22 (+0.78%)

Fundamental Rating

7

Overall ISRG gets a fundamental rating of 7 out of 10. We evaluated ISRG against 187 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ISRG a very profitable company, without any liquidiy or solvency issues. ISRG is not overvalued while it is showing excellent growth. This is an interesting combination. This makes ISRG very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year ISRG was profitable.
ISRG had a positive operating cash flow in the past year.
In the past 5 years ISRG has always been profitable.
Each year in the past 5 years ISRG had a positive operating cash flow.
ISRG Yearly Net Income VS EBIT VS OCF VS FCFISRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

With an excellent Return On Assets value of 12.88%, ISRG belongs to the best of the industry, outperforming 95.19% of the companies in the same industry.
ISRG's Return On Equity of 14.47% is amongst the best of the industry. ISRG outperforms 90.91% of its industry peers.
The Return On Invested Capital of ISRG (12.56%) is better than 94.65% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 7.89%.
The last Return On Invested Capital (12.56%) for ISRG is above the 3 year average (12.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.88%
ROE 14.47%
ROIC 12.56%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)12.3%
ROIC(5y)11.92%
ISRG Yearly ROA, ROE, ROICISRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of ISRG (28.41%) is better than 96.79% of its industry peers.
In the last couple of years the Profit Margin of ISRG has declined.
ISRG has a better Operating Margin (28.28%) than 97.33% of its industry peers.
In the last couple of years the Operating Margin of ISRG has declined.
ISRG's Gross Margin of 67.09% is fine compared to the rest of the industry. ISRG outperforms 72.19% of its industry peers.
ISRG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 28.28%
PM (TTM) 28.41%
GM 67.09%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
ISRG Yearly Profit, Operating, Gross MarginsISRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ISRG has been increased compared to 1 year ago.
The number of shares outstanding for ISRG has been increased compared to 5 years ago.
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ISRG Yearly Shares OutstandingISRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ISRG Yearly Total Debt VS Total AssetsISRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ISRG has an Altman-Z score of 56.77. This indicates that ISRG is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ISRG (56.77) is better than 100.00% of its industry peers.
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 56.77
ROIC/WACC1.41
WACC8.93%
ISRG Yearly LT Debt VS Equity VS FCFISRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 4.98 indicates that ISRG has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.98, ISRG is in the better half of the industry, outperforming 74.33% of the companies in the same industry.
ISRG has a Quick Ratio of 3.97. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.97, ISRG is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.98
Quick Ratio 3.97
ISRG Yearly Current Assets VS Current LiabilitesISRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

7

3. Growth

3.1 Past

ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.76%, which is quite impressive.
ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
Looking at the last year, ISRG shows a quite strong growth in Revenue. The Revenue has grown by 19.08% in the last year.
The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%

3.2 Future

Based on estimates for the next years, ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.45% on average per year.
The Revenue is expected to grow by 14.12% on average over the next years. This is quite good.
EPS Next Y9.17%
EPS Next 2Y12.26%
EPS Next 3Y13.94%
EPS Next 5Y14.45%
Revenue Next Year18.07%
Revenue Next 2Y16.6%
Revenue Next 3Y16.14%
Revenue Next 5Y14.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ISRG Yearly Revenue VS EstimatesISRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
ISRG Yearly EPS VS EstimatesISRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 71.31, ISRG can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ISRG is valued a bit cheaper than the industry average as 65.78% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.28. ISRG is valued rather expensively when compared to this.
ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 58.98.
Based on the Price/Forward Earnings ratio, ISRG is valued a bit cheaper than the industry average as 65.78% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.76. ISRG is valued rather expensively when compared to this.
Industry RankSector Rank
PE 71.31
Fwd PE 58.98
ISRG Price Earnings VS Forward Price EarningsISRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

ISRG's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 63.64% of the companies in the same industry.
ISRG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 70.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 111.89
EV/EBITDA 62.44
ISRG Per share dataISRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
ISRG's earnings are expected to grow with 13.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.78
PEG (5Y)6.21
EPS Next 2Y12.26%
EPS Next 3Y13.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ISRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTUITIVE SURGICAL INC

NASDAQ:ISRG (7/3/2025, 12:59:04 PM)

544.82

+4.22 (+0.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-17 2025-07-17/amc
Inst Owners88.74%
Inst Owner Change0.6%
Ins Owners0.45%
Ins Owner Change6.09%
Market Cap195.27B
Analysts79.49
Price Target593.62 (8.96%)
Short Float %1.12%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.91%
Min EPS beat(2)3.05%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)11.89%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.01%
EPS beat(12)10
Avg EPS beat(12)4.94%
EPS beat(16)13
Avg EPS beat(16)5.44%
Revenue beat(2)2
Avg Revenue beat(2)3.11%
Min Revenue beat(2)1.09%
Max Revenue beat(2)5.12%
Revenue beat(4)2
Avg Revenue beat(4)1.5%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)0.86%
PT rev (1m)-0.02%
PT rev (3m)-8.17%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)-2.25%
EPS NY rev (1m)0.3%
EPS NY rev (3m)-2.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.25%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 71.31
Fwd PE 58.98
P/S 22.41
P/FCF 111.89
P/OCF 71.5
P/B 11.42
P/tB 11.67
EV/EBITDA 62.44
EPS(TTM)7.64
EY1.4%
EPS(NY)9.24
Fwd EY1.7%
FCF(TTM)4.87
FCFY0.89%
OCF(TTM)7.62
OCFY1.4%
SpS24.31
BVpS47.73
TBVpS46.7
PEG (NY)7.78
PEG (5Y)6.21
Profitability
Industry RankSector Rank
ROA 12.88%
ROE 14.47%
ROCE 13.94%
ROIC 12.56%
ROICexc 17.02%
ROICexgc 17.52%
OM 28.28%
PM (TTM) 28.41%
GM 67.09%
FCFM 20.03%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)12.3%
ROIC(5y)11.92%
ROICexc(3y)22.09%
ROICexc(5y)21.23%
ROICexgc(3y)23.21%
ROICexgc(5y)22.47%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 185.49%
Cap/Sales 11.31%
Interest Coverage 250
Cash Conversion 91.16%
Profit Quality 70.49%
Current Ratio 4.98
Quick Ratio 3.97
Altman-Z 56.77
F-Score6
WACC8.93%
ROIC/WACC1.41
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
EPS Next Y9.17%
EPS Next 2Y12.26%
EPS Next 3Y13.94%
EPS Next 5Y14.45%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
Revenue Next Year18.07%
Revenue Next 2Y16.6%
Revenue Next 3Y16.14%
Revenue Next 5Y14.12%
EBIT growth 1Y32.36%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year33.95%
EBIT Next 3Y22.85%
EBIT Next 5Y19.86%
FCF growth 1Y73.18%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y66.62%
OCF growth 3Y4.95%
OCF growth 5Y8.61%